|Articles|November 15, 2001
- BioPharm International-11-01-2001
- Volume 14
- Issue 11
Liposomes (a Review), Part One: Manufacturing Issues
by Suggy S. Chrai, R. Murari, and Imran Ahmad Liposomal formulations are increasingly being used in biopharmaceutical development projects. Good manufacturing processes must reproducibly fabricate lipid vesicles that are as uniform in size as possible, carry the drug in sufficient concentration, and remain stable for an acceptable shelf-life under varying temperatures.
Advertisement
Articles in this issue
almost 24 years ago
Business Matters: Eclipsed by Catastrophealmost 24 years ago
Designs for Bioassays with Plate Location Effectsalmost 24 years ago
Simplifying Pharmacologic Analysis with Programmable Scientific Softwarealmost 24 years ago
Outsourcing Outlook: Truth in OutsourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
